About this Author
DBL%20Hendrix%20small.png College chemistry, 1983

Derek Lowe The 2002 Model

Dbl%20new%20portrait%20B%26W.png After 10 years of blogging. . .

Derek Lowe, an Arkansan by birth, got his BA from Hendrix College and his PhD in organic chemistry from Duke before spending time in Germany on a Humboldt Fellowship on his post-doc. He's worked for several major pharmaceutical companies since 1989 on drug discovery projects against schizophrenia, Alzheimer's, diabetes, osteoporosis and other diseases. To contact Derek email him directly: Twitter: Dereklowe

Chemistry and Drug Data: Drugbank
Chempedia Lab
Synthetic Pages
Organic Chemistry Portal
Not Voodoo

Chemistry and Pharma Blogs:
Org Prep Daily
The Haystack
A New Merck, Reviewed
Liberal Arts Chemistry
Electron Pusher
All Things Metathesis
C&E News Blogs
Chemiotics II
Chemical Space
Noel O'Blog
In Vivo Blog
Terra Sigilatta
BBSRC/Douglas Kell
Realizations in Biostatistics
ChemSpider Blog
Organic Chem - Education & Industry
Pharma Strategy Blog
No Name No Slogan
Practical Fragments
The Curious Wavefunction
Natural Product Man
Fragment Literature
Chemistry World Blog
Synthetic Nature
Chemistry Blog
Synthesizing Ideas
Eye on FDA
Chemical Forums
Symyx Blog
Sceptical Chymist
Lamentations on Chemistry
Computational Organic Chemistry
Mining Drugs
Henry Rzepa

Science Blogs and News:
Bad Science
The Loom
Uncertain Principles
Fierce Biotech
Blogs for Industry
Omics! Omics!
Young Female Scientist
Notional Slurry
Nobel Intent
SciTech Daily
Science Blog
Gene Expression (I)
Gene Expression (II)
Adventures in Ethics and Science
Transterrestrial Musings
Slashdot Science
Cosmic Variance
Biology News Net

Medical Blogs
DB's Medical Rants
Science-Based Medicine
Respectful Insolence
Diabetes Mine

Economics and Business
Marginal Revolution
The Volokh Conspiracy
Knowledge Problem

Politics / Current Events
Virginia Postrel
Belmont Club
Mickey Kaus

Belles Lettres
Uncouth Reflections
Arts and Letters Daily
In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

In the Pipeline

« What A Fool Believes | Main | The Cost to Develop a Drug: Your Own Numbers? »

March 10, 2011

Public Outreach

Email This Entry

Posted by Derek

Taking on questions from all comers about the drug industry, here I am over at Reddit's "Ask Me Anything" section. Have a look if you like - the questions vary greatly, is all I'll say. . .

Comments (11) + TrackBacks (0) | Category: Why Everyone Loves Us


1. Anon anon anon on March 10, 2011 10:31 AM writes...

Looks like people want the recreational-drug-and-conspiracy-theory combo platter. Oh, and to ask (again) what you studied.

Thanks for doing this! I think you gave people some food for thought.

Permalink to Comment

2. coprolite on March 10, 2011 10:36 AM writes...

Seems like you've made a friend in BongRoss.

Permalink to Comment

3. Anonymous on March 10, 2011 11:29 AM writes...

Because I don't have a reddit account...

How much unutilized and underutilized IP is held by your average large pharmaceutical company? It goes without saying that any discovery that seems likely to provide a significant return on investment will be pushed forward. But what about discoveries that fall just short in risk/cost analysis? Do they all sit languishing in locked file cabinets somewhere, or do pharmaceutical companies make an effort to sell off or publish information that might be worth something to someone else?

Permalink to Comment

4. RKN on March 10, 2011 12:49 PM writes...

Good grief, that was a tremendous volume of pro bono feedback from you. My question for you is: "How much sleep do you get on average night!"

Permalink to Comment

5. Derek Lowe on March 10, 2011 12:52 PM writes...

Fortunately, I type really, really quickly. . .

Permalink to Comment

6. Bunsen Honeydew on March 10, 2011 2:05 PM writes...

Some bozo on there is saying that a bone marrow transplant is a cure for HIV!!! WTF??!!

Permalink to Comment

7. Anonymous on March 10, 2011 2:59 PM writes...

the bozo is referring to the single case

Permalink to Comment

8. Bunsen Honeydew on March 10, 2011 3:40 PM writes...

How did I miss that in the news? That's pretty cool but certainly not an all out cure.

Permalink to Comment

9. Anon on March 10, 2011 10:49 PM writes...

Thanks for doing the AMA.

As someone new to your blog - and recommended place to start catching up? I can't find a list of most popular posts, etc

Permalink to Comment

10. coprolite on March 11, 2011 8:05 AM writes...

9.---Start at Things I Will Not Work With and go from there.

Permalink to Comment

11. John Shaffer on March 12, 2011 12:10 PM writes...

I thought I'd post this here too. GSK kept one TKI inhibitor and kicked XL184 to the curb. Then a positive study on XL184 in prostate Ca came out and EXEL did a secondary to fund P3 studies underwritten by GS. So what do you think?

Permalink to Comment


Remember Me?


Email this entry to:

Your email address:

Message (optional):

The Last Post
The GSK Layoffs Continue, By Proxy
The Move is Nigh
Another Alzheimer's IPO
Cutbacks at C&E News
Sanofi Pays to Get Back Into Oncology
An Irresponsible Statement About Curing Cancer
Oliver Sacks on Turning Back to Chemistry